U.S. Biotech Stock News

EQT (EQT) has attracted fresh attention after recent share price moves, with a 1 day return of 2% and a past week gain of 1.7%, prompting investors to reassess the natural gas producer. See our latest analysis for EQT. That short term lift sits against a 30 day share price return of 7.1% decline and a year to date share price return of 1.9%, while the 1 year total shareholder return of 12.5% and 5 year total shareholder return above 200% suggest momentum has generally been building over time...

Huron Consulting Group (HURN) drew fresh attention after Barrington Research named it one of its top stock ideas for 2026, following quarterly results that beat expectations and included higher full year earnings guidance. See our latest analysis for Huron Consulting Group. The recent endorsement from Barrington Research comes on top of strong third quarter results and appears to line up with building momentum, with a 90 day share price return of 21.49%, year to date share price return of...

What ComEd’s new agreements mean for Exelon stock Exelon (EXC) is back in focus after its utility unit ComEd introduced Transmission Security Agreements that shift more grid connection and transmission costs to new large load customers, rather than existing ratepayers. See our latest analysis for Exelon. Even with the recent softness in Exelon’s share price, including a 1 day share price return of 1.94% decline and a 90 day share price return of 7.87% decline to US$42.99, longer term total...

Coupang has come under pressure after South Korean officials and regulators criticized its handling of a major customer data breach and questioned the adequacy of its voucher-based compensation plan, while conflicting figures on affected accounts prompted calls for independent verification. At the same time, multiple US law firms have launched securities class actions alleging that Coupang misled investors about its cybersecurity controls and delayed disclosing the breach, bringing legal and...

Why Dynex Capital is on investors’ radar today Dynex Capital (DX) has been drawing attention after a period where returns over the past year and past 3 years stand well above its year to date move, prompting fresh questions about its valuation. See our latest analysis for Dynex Capital. Recent trading has been relatively steady, with a 90 day share price return of 7.72% and a 1 year total shareholder return of 30.60%. This hints that momentum has been building even as the latest share price...

This article examines whether Extreme Networks at US$16.14 is a bargain or a value trap by exploring what the current share price might be implying about the company. The stock has seen mixed returns, with a 3.1% decline over the last week, an 11.1% decline over the last month, a 2.4% decline year to date, a 7.7% decline over 1 year, a 16.1% decline over 3 years, and a 110.4% gain over 5 years. Recent coverage of Extreme Networks has focused on its position in the networking equipment space...

What Texas Instruments’ Recent Performance Signals for Investors Texas Instruments (TXN) has been drawing attention after a mixed pattern of recent returns, including a 0.03% daily decline, modest gains over the past week and month, and a slightly positive total return over the past year. See our latest analysis for Texas Instruments. With the latest share price at US$185.71, Texas Instruments has seen a 3.33% 1 day share price decline after a 7.04% 7 day share price return and a 4.61% year...

In recent weeks, Terns Pharmaceuticals reported encouraging Phase 1 data and strong enrollment for its CARDINAL trial of TERN-701 in chronic myeloid leukemia, alongside receiving US FDA Fast Track designation for the therapy in late 2025. The company also completed an upsized public offering of more than 18,600,000 shares at US$40.00 each, raising about US$747,500,000 in gross proceeds and extending its reported cash runway into 2031. Next, we’ll examine how TERN-701’s Fast Track status and...

If you are wondering whether lululemon athletica's current share price reflects its true value, you are not alone. Many investors are asking the same question right now. The stock last closed at US$211.72, with recent returns of 1.9% over 7 days, 15.7% over 30 days, 0.4% year to date, and a 46.1% decline over 1 year and 32.1% decline over 3 years, alongside a 39.9% decline over 5 years. Recent news flow around lululemon has kept attention on how the brand is positioned in the premium...

In recent days, Arcutis Biotherapeutics reported revenue growth of about 121.70%, reflecting strong momentum in its dermatology portfolio led by ZORYVE for plaque psoriasis and atopic dermatitis. This rapid expansion in dermatology revenue, alongside supportive analyst sentiment despite ongoing operating losses, highlights how ZORYVE is becoming central to Arcutis’ business profile. We’ll now examine how this very large revenue increase and growing ZORYVE traction may influence Arcutis...

SPX Technologies recently appointed Daniel Whitman as Vice President, General Counsel & Secretary, bringing over three decades of combined engineering and legal experience from roles at Parker Hannifin, Ingersoll-Rand, and other industrial-focused firms. At the same time, investor concern around Nvidia’s discussion of warm-water data center cooling has sharpened attention on how essential SPX’s cooling tower solutions remain in evolving infrastructure designs. Next, we’ll examine how...

Event context and recent share performance United Natural Foods (UNFI) stock has come under pressure recently, with the share price down about 4% over the past month and about 22% over the past 3 months, prompting investors to reassess the setup. See our latest analysis for United Natural Foods. That recent 3 month share price return of 21.61% decline sits against a more mixed picture, with United Natural Foods roughly flat on a year to date share price basis but a 1 year total shareholder...

In recent months, Gartner reported a strong third quarter with earnings beating estimates and record share repurchases, but later reduced its revenue growth guidance after contract value growth slowed amid tariff-related decision delays and budget pressures. At the same time, investors are weighing cyclical softness in Gartner’s core research business and concerns about generative AI’s impact on its value proposition ahead of upcoming earnings. We’ll now examine how slowing contract value...

This article walks through the key numbers on Chipotle Mexican Grill so you can judge for yourself whether it is still priced for perfection or starting to look interesting again. The stock last closed at US$38.87, with returns of 5.1% over 7 days, 15.7% over 30 days, 3.7% year to date, 31.4% over 3 years and a 32.9% decline over 1 year. Recent attention on Chipotle has centered on how its share price performance lines up with longer term expectations for the brand and the broader restaurant...

Insider selling and regulatory fight move into focus Fidelity National Financial (FNF) is back in the spotlight after director Halim Dhanidina sold 6,000 shares on January 5, 2026. At the same time, the company continues contesting FinCEN’s proposed anti money laundering rule for cash home sales. See our latest analysis for Fidelity National Financial. Those insider sales and the FinCEN dispute come as the stock trades at US$55.81, with a 1 day share price return of a 1.38% decline, a 1 year...

Advance Auto Parts has launched ARGOS, its new owned oil and fluids brand, developed through extensive customer feedback and testing to offer high-quality, affordable products for an aging U.S. vehicle fleet, with rollout across its Advance and Carquest locations and online beginning in early 2026. By keeping ARGOS exclusive to its own network, Advance Auto Parts is aiming to strengthen its product mix and potentially deepen relationships with both do-it-yourself and professional customers...

If you are wondering whether Constellation Brands is starting to look interesting at its current price, this breakdown will help you frame what that valuation really means for you as a shareholder or potential buyer. The stock last closed at US$140.49, with returns of 1.8% over the past 7 days, a 1.1% decline over 30 days, a 0.5% decline year to date, and a 34.3% decline over the last year. These movements can change how the market is thinking about both risk and opportunity. Recent coverage...

Snap-on (SNA) recently reported quarterly results, with revenue up 3.6% year on year and adjusted operating income ahead of analyst forecasts. The stock has moved about 6.5% higher since the release. See our latest analysis for Snap-on. At a share price of $352.58, Snap-on’s recent 6.5% post earnings move sits alongside a 90 day share price return of 6.3% and a 5 year total shareholder return of 133.7%. This points to momentum that has been building rather than fading. If Snap-on’s steady...

Are you wondering whether AGNC Investment is offering good value at today’s price, or if the recent run has moved it too far, too fast for new money to feel comfortable? The stock last closed at US$11.06, with returns of 3.2% over 7 days, 5.4% over 30 days, 1.2% year to date, 38.0% over 1 year and 55.1% over 3 years, plus 38.3% over 5 years. This raises a fair question about what is currently priced in. Recent attention on AGNC Investment has largely centered on its positioning in the...

If you are wondering whether Microchip Technology’s current share price reflects its true worth, you are not alone. This article is built to help you think through that question clearly. The stock last closed at US$73.94, with returns of 16.0% over 7 days, 9.8% over 30 days, 13.7% year to date and 35.3% over 1 year. The 3 year and 5 year returns sit at 5.5% and 8.5% respectively. Recent price moves have come alongside ongoing attention on the semiconductor sector, where investors continue to...

Why Brinker International is on investors’ radar now Brinker International (EAT) has caught investor attention after recent share price moves, with the stock showing double digit gains over the past 3 months and a 1 year total return above 10%. See our latest analysis for Brinker International. With the share price at $156.23 and a 90 day share price return of 25.55%, recent momentum has been strong, echoing a 1 year total shareholder return of 11.98% and a very large 3 year total shareholder...

Fresh 10-Q puts FactSet’s AI push and growth metrics in focus FactSet Research Systems (FDS) recently filed its latest Form 10-Q, spotlighting growth across key business metrics and wider use of embedded AI tools for data discovery, workflow automation, and client insight generation. See our latest analysis for FactSet Research Systems. Against this backdrop of new AI tools, FactSet’s recent share price has been relatively firm, with a 30 day share price return of 2.11% and a year to date...

Q1 2026 earnings snapshot UniFirst (UNF) opened its new fiscal year with Q1 2026 results anchored by prior quarter revenue of US$614.4 million and basic EPS of US$2.23, with trailing twelve month EPS at US$8.01 on US$2.4 billion of revenue and net income of US$148.3 million. Over recent quarters the company has seen revenue move from US$603.3 million in Q3 2024 to US$604.9 million in Q1 2025 and then to US$610.8 million and US$614.4 million in Q3 and Q4 2025, while quarterly EPS has tracked...

If you are wondering whether Estée Lauder Companies is still worth considering at around US$105.27, the key question is how that price stacks up against its underlying value. The stock has returned 0.5% over the last 7 days and 2.4% over the past month, sits on a 1.4% decline year to date, yet is up 45.4% over the last year. However, the 3 year and 5 year returns of 57.8% and 55.9% declines show a very different longer term picture. Recent headlines have focused on Estée Lauder's position in...